| Dr Brian C Lawler, MD | |
|
1 Medical Village Dr, Attn: Radiology Dept, Edgewood, KY 41017-3403 | |
| (859) 301-2160 | |
| (859) 301-3932 |
| Full Name | Dr Brian C Lawler |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 29 Years |
| Location | 1 Medical Village Dr, Edgewood, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235111279 | NPI | - | NPPES |
| 64035462 | Medicaid | KY | |
| 0060577 | Medicaid | OH | |
| P00844270 | Other | KY | RR MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 36672 (Kentucky) | Primary |
| 174400000X | Specialist | 36672 (Kentucky) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Elizabeth Edgewood | Edgewood, KY | Hospital |
| St Elizabeth Ft Thomas | Fort thomas, KY | Hospital |
| St Elizabeth Florence | Florence, KY | Hospital |
| Dearborn County Hospital | Lawrenceburg, IN | Hospital |
| St Elizabeth Grant | Williamstown, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Radiology Associates Of Northern Kentucky Pllc | 3779480736 | 44 |
| Radiology Associates Of Northern Kentucky Pllc | 3779480736 | 44 |
News Archive
The Hill: "Passing major healthcare reform legislation into law was worth taking a political beating, White House Chief of Staff Rahm Emanuel said Thursday… 'As [President Obama] said repeatedly, which is a sign, he was willing to spend, quote, unquote, 'the political capital' to get something done that was materially and politically, policy wise, important for the American people,' Emanuel told CNN in an interview, his first since the law passed, to air Thursday evening. 'And if you asked them, today, even - or a week ago, pre- the bill, was it worth the political capital spent, he would say, yes'" (Fabian, 3/25).
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing Teva's Biologics License Application (BLA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.
Studies performed by a Sanford Research scientist using an innovative stem-cell model for a fatal developmental disorder is the focus of a recent study published in Nature Medicine. Kevin Francis, Ph.D. uncovered unique cellular defects associated with Smith-Lemli-Opitz syndrome (SLOS) by modeling this disease using induced pluripotent stem cells.
But the Centers for Medicare and Medicaid Services chief says he remains entirely focused on the job at hand.
For World Heart Day 2021 and as part of its focus on leveraging its extensive knowledge, Atlantia Clinical Trials recently interviewed Professor Eric de Groot.
› Verified 2 days ago
| Entity Name | St Elizabeth Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932187937 PECOS PAC ID: 0648174623 Enrollment ID: O20031121000206 |
News Archive
The Hill: "Passing major healthcare reform legislation into law was worth taking a political beating, White House Chief of Staff Rahm Emanuel said Thursday… 'As [President Obama] said repeatedly, which is a sign, he was willing to spend, quote, unquote, 'the political capital' to get something done that was materially and politically, policy wise, important for the American people,' Emanuel told CNN in an interview, his first since the law passed, to air Thursday evening. 'And if you asked them, today, even - or a week ago, pre- the bill, was it worth the political capital spent, he would say, yes'" (Fabian, 3/25).
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing Teva's Biologics License Application (BLA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.
Studies performed by a Sanford Research scientist using an innovative stem-cell model for a fatal developmental disorder is the focus of a recent study published in Nature Medicine. Kevin Francis, Ph.D. uncovered unique cellular defects associated with Smith-Lemli-Opitz syndrome (SLOS) by modeling this disease using induced pluripotent stem cells.
But the Centers for Medicare and Medicaid Services chief says he remains entirely focused on the job at hand.
For World Heart Day 2021 and as part of its focus on leveraging its extensive knowledge, Atlantia Clinical Trials recently interviewed Professor Eric de Groot.
› Verified 2 days ago
| Entity Name | Radiology Associates Of Northern Kentucky Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073595179 PECOS PAC ID: 3779480736 Enrollment ID: O20031217000626 |
News Archive
The Hill: "Passing major healthcare reform legislation into law was worth taking a political beating, White House Chief of Staff Rahm Emanuel said Thursday… 'As [President Obama] said repeatedly, which is a sign, he was willing to spend, quote, unquote, 'the political capital' to get something done that was materially and politically, policy wise, important for the American people,' Emanuel told CNN in an interview, his first since the law passed, to air Thursday evening. 'And if you asked them, today, even - or a week ago, pre- the bill, was it worth the political capital spent, he would say, yes'" (Fabian, 3/25).
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing Teva's Biologics License Application (BLA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.
Studies performed by a Sanford Research scientist using an innovative stem-cell model for a fatal developmental disorder is the focus of a recent study published in Nature Medicine. Kevin Francis, Ph.D. uncovered unique cellular defects associated with Smith-Lemli-Opitz syndrome (SLOS) by modeling this disease using induced pluripotent stem cells.
But the Centers for Medicare and Medicaid Services chief says he remains entirely focused on the job at hand.
For World Heart Day 2021 and as part of its focus on leveraging its extensive knowledge, Atlantia Clinical Trials recently interviewed Professor Eric de Groot.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian C Lawler, MD Po Box 932163, Cleveland, OH 44193-0001 Ph: (586) 412-4000 | Dr Brian C Lawler, MD 1 Medical Village Dr, Attn: Radiology Dept, Edgewood, KY 41017-3403 Ph: (859) 301-2160 |
News Archive
The Hill: "Passing major healthcare reform legislation into law was worth taking a political beating, White House Chief of Staff Rahm Emanuel said Thursday… 'As [President Obama] said repeatedly, which is a sign, he was willing to spend, quote, unquote, 'the political capital' to get something done that was materially and politically, policy wise, important for the American people,' Emanuel told CNN in an interview, his first since the law passed, to air Thursday evening. 'And if you asked them, today, even - or a week ago, pre- the bill, was it worth the political capital spent, he would say, yes'" (Fabian, 3/25).
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing Teva's Biologics License Application (BLA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.
Studies performed by a Sanford Research scientist using an innovative stem-cell model for a fatal developmental disorder is the focus of a recent study published in Nature Medicine. Kevin Francis, Ph.D. uncovered unique cellular defects associated with Smith-Lemli-Opitz syndrome (SLOS) by modeling this disease using induced pluripotent stem cells.
But the Centers for Medicare and Medicaid Services chief says he remains entirely focused on the job at hand.
For World Heart Day 2021 and as part of its focus on leveraging its extensive knowledge, Atlantia Clinical Trials recently interviewed Professor Eric de Groot.
› Verified 2 days ago
Dr. Stephen G Moeller, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-2160 Fax: 859-301-3932 | |
Dr. Byron W Marks, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Village Drive, Edgewood, KY 41017 Phone: 859-301-2160 Fax: 859-301-3932 | |
Dr. Walter R Eiseman, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-2160 Fax: 859-301-3932 | |
Dr. Richard H Laib, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Village Drive, Edgewood, KY 41017 Phone: 859-301-2160 Fax: 859-301-3932 | |
Dr. James J Roebker, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-2160 Fax: 859-301-3932 | |
Dr. Elizabeth A P Reichard, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-2160 Fax: 859-301-3932 | |
David Jerome Lubbers, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-2160 Fax: 859-301-3932 |